Combination chemotherapy using TS-1, paclitaxel and cisplatin for multiple lung metastases from AFP-producing gastric cancer: A case report

Hepato-Gastroenterology

Volumn 54, Issue 76, 2007, Pages 1302-1304

  Usuba, Teruyuki ^a   Toyama, Yoichi ^a   Watanabe, Kazuhiro ^a   Kashiwagi, Hideyuki ^a   Yanaga, Katsuhiko ^b  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

AFP producing gastric cancer; Combination chemotherapy; Lung metastases

Indexed keywords

ALPHA FETOPROTEIN; CISPLATIN; FLUOROPYRIMIDINE DERIVATIVE; FLUOROURACIL; IRINOTECAN; PACLITAXEL; UFT;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RELAPSE; CANCER SIZE; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; GASTRECTOMY; GASTROINTESTINAL ENDOSCOPY; HUMAN; LEUKOPENIA; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; MALE; MONOTHERAPY; PRIORITY JOURNAL; STOMACH CANCER; STOMATITIS;

ALPHA-FETOPROTEINS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DRUG COMBINATIONS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OXONIC ACID; PACLITAXEL; STOMACH NEOPLASMS; TEGAFUR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34347331379     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Mclntire KR, Waldman TA, Moertel CG, Go VL: Serum α-fetoprotein in patients with neoplasms of the gastrointestinal tract. Cancer Res 1975; 35:991-996.
2. Chang Y-C, Nagasue N, Kohno H, Taniura H, Uchida M, Yamanoi A, Kimoto T, Nakamura T: Clinicopathologic features and long-term results ofα-fetoprotein-producing gastric cancer. Am J Gastroenterol 1990; 85:1480-1485.
3. Chang Y-C, Nagasue N, Abe S, Kohno H, Kumar DD, Nakamura T: Alpha fetoprotein producing early gastric cancer with liver metastasis: report of three cases. Gut 1991; 32: 542-545.
4. Chung Y-C, Nagasue N, Abe S, Tanimura H, Kumar DD, Nakamura T: Comparison between the clinicopathologic features of AFP-positive and AFP-negative gastric cancers. Am J Gastroenterol 1992; 87:321-325.
5. Kanemitsu Y, Kondo H, Katai H, Nakayama H, Asamura H, Tsuchiya R, Naruke T: Surgical resection of pulmonary metastases from gastric cancer. J Surg Oncol 1998; 69:147-150.
6. Urabe M, Sakakibara T, Daibo M: Two cases of recurrent pulmonary metastasis resected after operation for gastric cancer. Arch Jpn Chir 1996; 65:22-29.
7. Sakata Y, Ohtsu A, Horikoshi N, Sugimachi K, Mitachi Y, Taguchi T: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur-0.4 M gimestat-1M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 1998; 34:1715-1720.
8. Ohtsu A, Boku N, Nagashima F: A phase I/ II study of S-1 plus cisplatin (CDDP) in patients (pts.) with advanced gastric cancer (AGC). Proc ASCO 2001; 20:165a.
9. David R, KohlerDR, Goldspiel BR: Evalution of new drugs. Paclitaxel (Taxol). Pharmacotherapy 1994; 14:3-34.
10. Ohtsu A, Boku N,Tamura F, Muro K, Shimada Y, Saigenji K, Akazawa S, Kitajima M, Kanamaru R, Taguchi T: An early phase II study of a 3-hour infusion of paclitaxel for advanced gastric cancer. Am J Clin Oncol 1998; 21:416-419.
11. Ohtsu A, Shirao K, Miyata Y: A phase II study of three-hour infusional paclitaxel in patients with advanced gastric cancer. Proc ASCO 2000; 19:303a.